Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Journal of Clinical Oncology | 2013 | 2.6K |
Metal-organic frameworks and self-assembled supramolecular coordination complexes: comparing and contrasting the design, synthesis, and functionality of metal-organic materials | Chemical Reviews | 2013 | 2.3K |
Alpha emitter radium-223 and survival in metastatic prostate cancer | New England Journal of Medicine | 2013 | 2.1K |
A near-infrared fluorophore for live-cell super-resolution microscopy of cellular proteins | Nature Chemistry | 2013 | 607 |
Cancer heterogeneity: implications for targeted therapeutics | British Journal of Cancer | 2013 | 549 |
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy | Journal of Clinical Oncology | 2013 | 462 |
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial | Lancet Oncology, The | 2013 | 438 |
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2013 | 390 |
Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment | ACS Nano | 2013 | 386 |
In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures | Circulation | 2013 | 366 |
The clinical relevance of cancer cell lines | Journal of the National Cancer Institute | 2013 | 341 |
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007 | Thorax | 2013 | 317 |
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population | Lancet Oncology, The | 2013 | 266 |
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma | Cancer Discovery | 2013 | 249 |
ZnO nanowire arrays for enhanced photocurrent in PbS quantum dot solar cells | Advanced Materials | 2013 | 226 |
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma | Annals of Oncology | 2013 | 225 |
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2013 | 223 |
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer | Investigational New Drugs | 2013 | 220 |
Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases | European Radiology | 2013 | 217 |
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients | Journal of Allergy and Clinical Immunology | 2013 | 214 |
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease | Neuro-Oncology | 2013 | 195 |
Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound | Experimental Neurology | 2013 | 190 |
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2013 | 185 |
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial | Stroke | 2013 | 167 |
Factors predicting late recurrence for estrogen receptor-positive breast cancer | Journal of the National Cancer Institute | 2013 | 156 |